After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there's still a way forward for psychedelic medicines, experts said at HLTH.
More than two dozen Black and Latino health tech leaders have endorsed Kamala Harris for president. Another group of over 500 ...
A panel of experts at the HLTH conference agreed that states with strict abortion measures are likely to see negative ...
The designer Charles Eames famously said, “Never delegate understanding.” I wholeheartedly agree. But, as a leader, I also recognize the value and necessity of learning from those who are ...
We have been talking about value-based care for over 20 years and about interoperability in healthcare for at least as long. We have been talking about having data on care practices for roughly ...
In the life of a health system CEO, there is always something to worry about. This has been especially true for Tampa General Hospital CEO John Couris in the past few weeks. His organization has ...
Alzheimer’s disease medicines commercialized in the past two years validated amyloid beta as a drug target, but these antibody therapies still have a hard time penetrating the membrane that ...
The past couple of years have been rocky for companies looking to disrupt the traditional primary care model — with top retailers Walmart and Walgreens announcing that they’re winding down ...
INVEST 2024 Pitch Perfect Winner of the Consumer/Employer track Beth Schinkel, Co-founder and CEO, Mother's Milk is Best (right) with Arundhati Parmar, Editor-in-Chief, MedCity News (left) If you ...
Healthcare costs for employers are on the rise, and a large part of that is due to pharmacy expenses. Through a new partnership announced last week, HealthJoy and Mark Cuban Cost Plus Drug Company ...
The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...
The field of pathology, an integral part of the healthcare system, is approaching a crisis point, as constant and growing demand for pathology services threatens to outweigh the number of ...